A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Adalimumab
Related studies linked through entity extraction aliases.
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
- Status
- COMPLETED
- Phase
- PHASE3
Study of Adalimumab in Participants With Peripheral Spondyloarthritis (SpA)
- Status
- COMPLETED
- Phase
- PHASE3
Adalimumab in Axial Spondyloarthritis (ASIM) - MRI and Biomarkers in Patients With Spondyloarthritis
- Status
- COMPLETED
- Phase
- PHASE4
Adalimumab in Rheumatoid Arthritis. An Investigation of Wholebody MRI, Conventional MRI, CT and Circulating Biomarkers
- Status
- COMPLETED
- Phase
- N/A
Effectiveness and Safety of Spondylitis Related to Inflammatory Bowel Disease
- Status
- WITHDRAWN
- Phase
- PHASE4
Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE4
Study of Adalimumab in Patients With Axial Spondyloarthritis
- Status
- COMPLETED
- Phase
- PHASE3
Abatacept Versus Adalimumab Head-to-Head
- Status
- COMPLETED
- Phase
- PHASE3
Study of Adalimumab in Subjects With Moderate to Severe Chronic Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE2
Intravitreal Adalimumab in Refractory Diabetic Retinopathy, Choroidal Neovascularization or Uveitis: A Pilot Study
- Status
- UNKNOWN
- Phase
- PHASE1
A Study of Adalimumab in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
- Status
- COMPLETED
- Phase
- PHASE3
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
To Assess the Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Hidradenitis Suppurativa
- Status
- COMPLETED
- Phase
- PHASE2
Bone Resorption, Osteoclastogenesis and Adalimumab
- Status
- COMPLETED
- Phase
- NA
Novel Therapies for Resistant FSGS (FONTII): Phase II Clinical Trial
- Status
- COMPLETED
- Phase
- PHASE2
A Pilot Study of the Feasibility of Discontinuation of Adalimumab in Stable Rheumatoid Arthritis Patients in Clinical Remission
- Status
- COMPLETED
- Phase
- PHASE4
Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)
- Status
- TERMINATED
- Phase
- PHASE4
Juvenile Idiopathic Arthritis (JIA) Registry
- Status
- COMPLETED
- Phase
- N/A
Active Juvenile Idiopathic Arthritis (JIA) Compassionate Use
- Status
- COMPLETED
- Phase
- PHASE3